Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version
SECTIONS
- General Information About Small Cell Lung Cancer (SCLC)
- Cellular Classification of SCLC
- Stage Information for SCLC
- Treatment Option Overview for SCLC
- Limited-Stage SCLC Treatment
- Extensive-Stage SCLC Treatment
- Recurrent SCLC Treatment
- Changes to This Summary (07/19/2018)
- About This PDQ Summary
- View All Sections
Changes to This Summary (07/19/2018)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Updated staging information for 2017 (cited American Joint Committee on Cancer as reference 1).
Added text about the phase III CONVERT study (NCT00433563) (cited Faivre-Finn et al. as reference 21 and level of evidence 1iiA).
This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
.png)
No hay comentarios:
Publicar un comentario